Preferential Subsarcolemmal Localization of Dystrophin and β-dystroglycan mRNA in Human Skeletal Muscles

15Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The intracellular localization of dystrophin and β-dystroglycan mRNA in skeletal muscles of patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) and normal subjects was examined by in situ hybridization using biotinylated oligonucleotide probes. These mRNAs were found preferentially in sarcolemma in the skeletal muscles of both normal subjects and affected patients. Quantitative analysis of mRNA signals demonstrated no prominent reduction of dystrophin or β-dystroglycan mRNA in DMD/BMD muscles. These results suggest that even mRNAs with deletions contain specific information that affects their localization, and the characteristic defect of dystrophin in DMD/BMD muscles seems to be caused mainly by the instability of dystrophin protein, as a post-transcriptional event.

Cite

CITATION STYLE

APA

Mitsui, T., Kawai, H., Shono, M., Kawajiri, M., Kunishige, M., & Saito, S. (1997). Preferential Subsarcolemmal Localization of Dystrophin and β-dystroglycan mRNA in Human Skeletal Muscles. Journal of Neuropathology and Experimental Neurology, 56(1), 94–101. https://doi.org/10.1097/00005072-199701000-00010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free